Pancreatic cancer is one of the harshest and most challenging cancers to treat, often labeled
as incurable. Chemotherapy continues to be the most popular treatment yet yields a very …

Despite rapid advances in cancer diagnosis and treatment, pancreatic cancer remains one
of the most difficult human malignancies to be treated, with a mortality rate nearly equal to its …

Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …

Published literature on cancer by health agencies and health organizations reveals
increased cancer incidence year by year. The first line of cancer treatment involves one or …

Chemotherapy is the routine treatment for cancer despite the poor efficacy and associated
off‐target toxicity. Furthermore, therapeutic doses of chemotherapeutic agents are limited …

Colorectal cancer (CRC) is the third most common cancer and the fourth most common
deadly cancer worldwide. After treatment with curative intent recurrence rates vary with …

In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …

The use of liposomes for drug delivery began early in the history of pharmaceutical
nanocarriers. These nanosized, lipid bilayered vesicles have become popular as drug …

Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

Liposomes, with their flexible physicochemical and biophysical properties, continue to be
studied as an important potential a critical drug delivery system. Liposomes have overcome …